Biotechnology Stocks I Performance Guide: Denali Therapeutics Inc. (DNLI)
DNLI has no dividends.
Table and Chart of DNLI Performance
See what a $1,000 investment in DNLI is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DNLI Returns | |
|---|---|
| Start Date | Jan-31-2018 |
| Start Price | $23.26 |
| End Date | May-10-2024 |
| End Price | $18.31 |
| # Prices | 77 |
| Min Date | Jul-31-2018 |
| Min Price | $12.59 |
| Max Date | Dec-31-2020 |
| Max Price | $83.76 |
| Total Return | -21.28% |
| Annualized Return | -3.66% |
| Current Value of $1,000 Purchase | $787 |
| Number Returns | 2,926 |
| Average Return | 34.57% |
| Number Profitable Returns | 1,634 |
| Percent Profitable Returns | 55.84% |
| Number Unprofitable Returns | 1,292 |
| Percent Unprofitable Returns | 44.16% |
| Profitable to Unprofitable Returns Ratio | 1.26 |
| DNLI Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,663,940,000 |
| Beta | 1.389 | Price to Sales | 7.69 |
| Earnings per Share | $-0.9400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.465 |
| PRICE DATA | |
| 52 Week High | $33.31 |
| 52 Week Low | $14.56 |
| Analyst Target Price | $39.69 |
| 50-Day Moving Average | $18.73 |
| 200-Day Moving Average | $20.11 |
| FINANCIAL DATA | |
| Revenue per Share | $2.101 |
| Revenue | $295,390,000 |
| Profit Margin | -46.5% |
| Return on Equity | -11.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DNLI Compare Returns with S&P 500
DNLI Trendline Chart
DNLI Moving Average Chart
DNLI Stock Return Map - See Patterns of Gains and Losses
DNLI Stock Returns/Purchase Dates